Clinical trials

  • IMATINIB MESILATE for Gastrointestinal stromal tumor (advanced/metastatic)
  • Floxuridin for Resectable colorectal liver metastases (no extrahepatic disease)
  • Anastrozole for Locally advanced or metastatic low-grade endometrial stromal sarcoma
  • 1-[[(5R)-2-[4-(5-CHLORO-2-PYRIMIDINYL)-1-PIPERIDINYL]-6,7-DIHYDRO-5-OXIDOTHIENO[3,2-D]PYRIMIDIN-4-YL]AMINO]-CYCLOBUTANEMETHANOL for Systemic autoimmune rheumatic disease-associated interstitial lung disease (SARD-ILD)
  • GALLIUM (68GA), PENTIXAFOR for Primary aldosteronism
  • AFAMITRESGENE AUTOLEUCEL for Myxoid/Round cell liposarcoma | Synovial sarcoma
  • CROFELEMER for Microvillus inclusion disease (MVID)
  • TIRAGOLUMAB for Head and neck squamous cell carcinoma (HNSCC) | dMMR/MSI-high (deficient mismatch repair) metastatic cancer | Metastatic melanoma | Locally advanced or metastatic solid tumour
  • Progesterone for Infertility
  • LUTETIUM (177LU) OXODOTREOTIDE for Recurrent or relapsed solid tumours expressing somatostatin receptors
  • AXICABTAGENE CILOLEUCEL for Diffuse large B-cell lymphoma
  • SODIUM HYPOCHLORITE for Diabetic foot ulcer